Phlow Corp.
- Feb 14, 2025 · D · $30,527,397 sold of $40,000,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
- Jul 10, 2024 · D · $5,000,000 sold of $25,000,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
- Sep 2, 2022 · D · $24,200,000 sold of $50,000,000 · 11 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
- Nov 20, 2020 · D · $15,000,000 sold of $20,000,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
- Nov 18, 2020 · D · $0 sold of $8,062,500 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Raised $30.5M from 11 investors (76% of the $40M target) as of the latest filing. Eric is listed as executive officer, director on 5 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.